Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02087280

Metabolic Phenotyping in Anorexia Nervosa

Metabolic Phenotyping to Predict Risk of Relapse in Patients With Anorexia Nervosa

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
Female
Age
12 Years – 18 Years
Healthy volunteers
Accepted

Summary

After discharge from inpatient treatment, 30-50% of patients with Anorexia Nervosa require re-hospitalization within 4-12 months. So far, high relapse rates are mostly considered as lack of the patient's compliance and motivation to recover. However in studies, psychological relapse predictors explain only a minor part of the variance in relapse risk. Metabolic phenotyping has clinical value to predict weight course in obese patients and we assume that it could also be clinically relevant in patients with AN. We hypothesize that in patients with a dissipative but not with the thrifty phenotype, positive energy balance during refeeding causes an over proportional rise in energy expenditure, counteracts continuous weight gain during inpatient treatment, and increases relapse risk within one year after discharge. Thus we believe that metabolic phenotype as a biological parameter has prognostic value for the disease course in AN.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2014-03-14
Last updated
2017-02-13

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02087280. Inclusion in this directory is not an endorsement.